Project Number 14/17390-9-2015 Agency/Funding Organization São Paulo Research Foundation (FAPESP) Funding Year 2015 View Full Project Details for Design and development of new potential anti-Alzheimer agents based on the inhibition of acetylcholinesterase and glycogen synthase kinase 3-beta and anti-aggregation of the amyloid beta-peptide Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 4. Non-clinical Drug Development (small molecules and biologics) a. Amyloid beta Researcher and Organization Principal Investigator Silva, Carlos Henrique Tomich de Paula da Principal Investigator First Name Carlos Henrique Tomich de Paula da Principal Investigator Last Name Silva Awardee Organization Faculdade de Ciências Farmacêuticas de Ribeirão Preto (FCFRP). Universidade de São Paulo (USP) Contact PI Country Brazil Project Detail FY Overall Cost $24,418 Funding Organization Agency/Funding Organization São Paulo Research Foundation (FAPESP) Funding Organization Country Brazil Program Official Godoi, Simone sgodoi@fapesp.br
